180 related articles for article (PubMed ID: 29196782)
1. Adapting to insulin resistance in obesity: role of insulin secretion and clearance.
Jung SH; Jung CH; Reaven GM; Kim SH
Diabetologia; 2018 Mar; 61(3):681-687. PubMed ID: 29196782
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the relationship between obesity and hyperinsulinemia: Role of insulin secretion and insulin clearance.
Kim MK; Reaven GM; Kim SH
Obesity (Silver Spring); 2017 Feb; 25(2):378-383. PubMed ID: 28000428
[TBL] [Abstract][Full Text] [Related]
3. Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance.
Carantoni M; Abbasi F; Azhar S; Chen YD; Klebanov M; Wang PW; Warmerdam F; Reaven GM
Diabetes; 1998 Feb; 47(2):244-7. PubMed ID: 9519720
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinemia in individuals with obesity: Role of insulin clearance.
Kim MK; Reaven GM; Chen YD; Kim E; Kim SH
Obesity (Silver Spring); 2015 Dec; 23(12):2430-4. PubMed ID: 26524351
[TBL] [Abstract][Full Text] [Related]
5. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults.
Farin HM; Abbasi F; Reaven GM
Am J Clin Nutr; 2006 Jan; 83(1):47-51. PubMed ID: 16400048
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.
McLaughlin T; Allison G; Abbasi F; Lamendola C; Reaven G
Metabolism; 2004 Apr; 53(4):495-9. PubMed ID: 15045698
[TBL] [Abstract][Full Text] [Related]
7. Habitual shortened sleep and insulin resistance: an independent relationship in obese individuals.
Liu A; Kushida CA; Reaven GM
Metabolism; 2013 Nov; 62(11):1553-6. PubMed ID: 23849514
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.
Kim SH; Abbasi F; Chu JW; McLaughlin TL; Lamendola C; Polonsky KS; Reaven GM
Diabetes; 2005 Aug; 54(8):2447-52. PubMed ID: 16046313
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
[TBL] [Abstract][Full Text] [Related]
10. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome.
Dahan MH; Reaven G
Endocrine; 2019 Jun; 64(3):685-689. PubMed ID: 30900204
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers.
Wang PW; Abbasi F; Carantoni M; Chen YD; Azhar S; Reaven GM
J Clin Endocrinol Metab; 1997 Oct; 82(10):3221-4. PubMed ID: 9329342
[TBL] [Abstract][Full Text] [Related]
12. Directly measured insulin resistance and the assessment of clustered cardiovascular risks in hypertension.
Lin MW; Hwu CM; Huang YH; Sheu WH; Shih KC; Chiang FT; Olshen R; Chen YD; Curb JD; Rodriguez B; Ho LT;
Am J Hypertens; 2006 Nov; 19(11):1118-24. PubMed ID: 17070421
[TBL] [Abstract][Full Text] [Related]
13. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between obesity and insulin resistance in the association with C-reactive protein.
McLaughlin T; Abbasi F; Lamendola C; Liang L; Reaven G; Schaaf P; Reaven P
Circulation; 2002 Dec; 106(23):2908-12. PubMed ID: 12460870
[TBL] [Abstract][Full Text] [Related]
15. Relationship between obesity, insulin resistance, and coronary heart disease risk.
Abbasi F; Brown BW; Lamendola C; McLaughlin T; Reaven GM
J Am Coll Cardiol; 2002 Sep; 40(5):937-43. PubMed ID: 12225719
[TBL] [Abstract][Full Text] [Related]
16. Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects.
Gniuli D; Castagneto-Gissey G; Iaconelli A; Leccesi L; Mingrone G
Int J Obes (Lond); 2010 Dec; 34(12):1726-32. PubMed ID: 20498658
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance & secretion in subjects with normal fasting plasma glucose.
Hsieh CH; Hung YJ; Wu CZ; Lee SS; Lee CH; Chen CY; Li JC; Kuo SW; Kuo KL; Pei D
Indian J Med Res; 2006 Nov; 124(5):527-34. PubMed ID: 17213521
[TBL] [Abstract][Full Text] [Related]
18. Persistence of improvement in insulin sensitivity following a dietary weight loss programme.
McLaughlin T; Schweitzer P; Carter S; Yen CG; Lamendola C; Abbasi F; Reaven G
Diabetes Obes Metab; 2008 Dec; 10(12):1186-94. PubMed ID: 18476986
[TBL] [Abstract][Full Text] [Related]
19. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
Evans DJ; Murray R; Kissebah AH
J Clin Invest; 1984 Oct; 74(4):1515-25. PubMed ID: 6148358
[TBL] [Abstract][Full Text] [Related]
20. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects.
Rosolova H; Mayer O; Reaven G
J Clin Endocrinol Metab; 1997 Nov; 82(11):3783-5. PubMed ID: 9360541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
